FLT vs RCUS
FLT (FLT) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
FLT (FLT) common stock.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
FLT does not have a complete income-statement cache yet.
Latest reported RCUS revenue for 2024-12-31 was $258.0M. Net income was -$283.0M. Revenue was up 120.5% from 2023-12-31 to 2024-12-31. RCUS currently screens at market cap $885.2M.
RCUS currently screens at market cap $885.2M.
Not investment advice. Open the FLT and RCUS stock pages for the full models.
Not investment advice.